文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

前列腺癌水凝胶间隔物放疗后生活质量:5年结果

Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year Results.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2017-05-31

研究纳入2010至2011年接受前列腺外照射放疗的114例患者,其中54例在放疗前注射水凝胶间隔物。采用经验证问卷评估至放疗后中位63个月的生活质量,结果显示水凝胶组肠道功能与困扰评分仅在放疗结束时出现>5分的一过性变化,无患者报告肠道习惯中重度问题。

要点

  • 水凝胶组肠道功能与困扰评分仅在放疗结束时较基线变化>5分(10-15分,P<.01)。
  • 无间隔物组肠道困扰评分在放疗结束时变化21分,放疗后63个月仍为6分。
  • 肠道困扰评分变化>10分者,17个月时间隔物组6% vs 无间隔物组32%(P<.01)。

核心结论

  • 前列腺癌水凝胶间隔物放疗后5年生活质量结果示治疗耐受性良好,尤其肠道问题方面。

研究设计与样本

  • 2010至2011年114例前列腺癌患者接受外照射放疗,54例放疗前注射水凝胶间隔物。
  • 放疗剂量为76 Gy(n=96)或78 Gy(n=18,均用水凝胶),分次2 Gy。
  • 放疗前、放疗最后一天及放疗后中位2、17、63个月用EPIC问卷评估。

主要发现

  • 水凝胶组肠道功能与困扰评分较基线变化>5分仅见于放疗结束时(10-15分,P<.01)。
  • 水凝胶组无患者报告肠道习惯中重度问题。
  • 无间隔物组肠道困扰评分变化在放疗结束时为21分、2个月为8分、17个月为7分、63个月为6分。
  • 肠道困扰评分变化>10分者,17个月时水凝胶组6% vs 无间隔物组32%(P<.01),63个月时5% vs 14%(P=.2)。

关键数值与推荐

  • 平均评分变化>5分定义为临床相关。

临床怎么用

  • 水凝胶间隔物可减轻前列腺癌放疗期间及之后的肠道困扰,支持其用于改善治疗耐受性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate quality of life changes up to 5 years after prostate cancer radiation therapy (RT) with a hydrogel spacer. METHODS AND MATERIALS: In the years 2010 to 2011, 114 patients received external beam radiation therapy to the prostate; 54 patients were selected for a hydrogel injection before the beginning of RT. Treatment was performed applying fractions of 2 Gy up to a total dose of 76 Gy (n=96) or 78 Gy (n=18, all with hydrogel). Patients were surveyed before RT; at the last day of RT; and a median time of 2 months, 17 months, and 63 months after RT using a validated questionnaire (Expanded Prostate Cancer Index Composite). A mean score change of >5 points was defined as clinically relevant. RESULTS: For patients treated with a hydrogel spacer, mean bowel function and bother score changes of >5 points in comparison with baseline levels were found only at the end of RT (10-15 points; P<.01). No spacer patient reported moderate or big problems with his bowel habits overall. Mean bother score changes of 21 points at the end of RT, 8 points at 2 months, 7 points at 17 months, and 6 points at 63 months after RT were found for patients treated without a spacer. A bowel bother score change >10 points was found in 6% versus 32% (P<.01) at 17 months and in 5% versus 14% (P=.2) at 63 months with versus without a spacer. CONCLUSIONS: The first 5-year quality of life results in a group of prostate cancer patients treated with a hydrogel spacer demonstrate excellent treatment tolerability, in particular regarding bowel problems. Further studies with dose-escalated or re-irradiation concepts can be encouraged.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Pinkawa M, Berneking V, Schlenter M, et al. Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year Results. Int J Radiat Oncol Biol Phys. 2017. PMID: 28871986. doi:10.1016/j.ijrobp.2017.05.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。